COVID-19 vaccines - Safety update: 10 November 2022
Submitted by Anonymous (not verified) on 1 December 2023 - 12:33
COVID-19 vaccines - Safety update: 10 November 2022
COVID-19 vaccines - Safety update: 8 September 2022
Submitted by Anonymous (not verified) on 1 December 2023 - 12:33
COVID-19 vaccines - Safety update: 8 September 2022
Ciprofloxacin (systemic use) : List of nationally authorised medicinal products - PSUSA/00000775/202304
Submitted by Anonymous (not verified) on 1 December 2023 - 12:26
Ciprofloxacin (systemic use) : List of nationally authorised medicinal products - PSUSA/00000775/202304
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
Submitted by Anonymous (not verified) on 1 December 2023 - 12:15
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
BCG (bacillus calmette-guérin) for Immunotherapy : List of nationally authorised medicinal products - PSUSA/00000303/202303
Submitted by Anonymous (not verified) on 1 December 2023 - 12:14
BCG (bacillus calmette-guérin) for Immunotherapy : List of nationally authorised medicinal products - PSUSA/00000303/202303
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
Submitted by Anonymous (not verified) on 1 December 2023 - 12:00
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
Submitted by Anonymous (not verified) on 1 December 2023 - 11:15
COVID-19 vaccines - Safety update: 10 November 2022
Submitted by Anonymous (not verified) on 1 December 2023 - 11:00
COVID-19 vaccines - Safety update: 10 November 2022
COVID-19 vaccines - Safety update: 8 September 2022
Submitted by Anonymous (not verified) on 1 December 2023 - 11:00
COVID-19 vaccines - Safety update: 8 September 2022
Referral: Pseudoephedrine-containing medicinal products, pseudoephedrine, Article 31 referrals, Recommendation provided by Pharmacovigilance Risk Assessment Committee, 01/12/2023
Submitted by Anonymous (not verified) on 1 December 2023 - 11:00
Referral: Pseudoephedrine-containing medicinal products, pseudoephedrine, Article 31 referrals, Recommendation provided by Pharmacovigilance Risk Assessment Committee, 01/12/2023